Improve International Ltd. has been acquired by RJD Partners

Benchmark Holdings Plc. has sold Improve International Ltd. to RJD Partners.

Improve International provides both specialist postgraduate courses and qualifications as well as continuing professional development training to veterinary professionals. Its key programs are structured on a modular basis comprising both face-to-face practical and classroom learning as well as online delivery. With offices in the UK and Portugal, the business has global operations across the US, Australia and Japan. Courses are also available in multiple languages.

Founded in 2000, RJD Parters is an equity investor specializing in buy-outs, buy-ins and development capital for deals worth up to US$60 million.

Benchmark Holdings develops products and solutions in genetics, health and nutrition that improve performance, animal health and welfare, and reduce environmental impact across the aquaculture production cycle.

Oaklins Cavendish, based in the UK, advised the seller on this transaction.

DIENSTLEISTUNG

Verkauf

PARTEIEN

«I would thoroughly recommend the Oaklins Cavendish team to anyone looking to maximize the proceeds from a disposal or asset sale. The team are both consummate professionals, focused on delivery and pragmatic and flexible in their approach to helping their clients achieve their objectives. I would not hesitate to recommend them and would hope to work with them on future projects. They provide great value.»

James Banfield

Head of Knowledge Services, Benchmark Holdings Plc.

Sprechen Sie mit dem Deal Team

Andrew Jeffs

Partner

London, Grossbritannien
Oaklins Cavendish

Kurzprofil Kontakt aufnehmen

Rebecca McCredie

Director

London, Grossbritannien
Oaklins Cavendish

Kurzprofil Kontakt aufnehmen

Transaktionen

Rindegastos has been acquired by Visma

TMT

Rindegastos has been acquired by Visma

Rindegastos S.p.A. has been acquired by Visma. The transaction involved the sale of 100% of the company, with 60% of the shares transferred at closing and the remaining shares to be sold through deferred payments, contingent on Rindegastos’ future performance. This structure aims to align incentives around the company’s continued growth and expansion, ensuring a change of control that reflects Rindegastos’ long-term vision and expectations.

Mehr erfahren

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Private Equity | Energie

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Mehr erfahren

Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.

Gesundheitswesen

Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.

Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.

Mehr erfahren